World of DTC Marketing

MARCH 22, 2021

SUMMARY: Television remains the most important medium for healthcare advertising , accounting for 54.7% of all spend in 2018, far higher than television’s 30.8% share of the advertising market as a whole. However, recent trends indicate that healthcare marketers are shifting more dollars to digital ads. The shift to digital advertising doesn’t make sense when pharma product websites don’t meet consumers’ needs.

Media 261

Media Pharma Prescription Healthcare 261

Dominic Tyer

MARCH 25, 2021

This episode of the pharmaphorum podcast features digital transformation leader Edwin Erckens talking about the nature of digital innovation in the pharmaceutical industry.

Pharma 130

Pharma Pharmaceutical 130

Pharma Marketing Network

MARCH 23, 2021

Innovation During COVID-19 Fact Sheet. We compiled a fact sheet on innovations in digital publishing that sparked due to the pandemic and have since been soaring. . Get your complimentary copy of "The Publishing Industry: The Soar of Innovation During COVID-19 Fact Sheet". Name *. First. Last. Company Email *. Lead Source * Web Active Prospecting Sales Ad-Label Advertising - Offline Advertising - Online Advertising - Online - FocalPoint Advertising - Online - Mobile Advertising - Online - Trend

Healthcare 72

Healthcare Healthcare Networking Prospecting 72

pharmaphorum

MARCH 25, 2021

Previously viewed as a ‘nice to have’ for the pharma industry, virtual clinical trials were already moving from a theoretical to a practical proposition before COVID-19 accelerated their transition. This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), will take place on Thursday 25th March 15:30 GMT / 16:30 CET and look at where virtual trials fit into the next generation of commercial clinical research.

Pharma 52

Pharma Patients 52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

World of DTC Marketing

MARCH 21, 2021

SUMMARY: The goal of business is to maximize profits for shareholder returns but when a company that serves the public good pays CEOs millions of dollars in compensation while having among the highest profit margins within ANY industry I would argue that something is dreadfully wrong. The U.S. pharmaceutical firms behind the approved coronavirus vaccines — Johnson & Johnson, Moderna, and Pfizer — have quietly touted plans to raise prices on coronavirus vaccines in the near future and to capi

Patients 201

Patients Pharma Healthcare Healthcare 201

Silver Line CRM

MARCH 22, 2021

Reading time: 4 minutes Patient centricity. Patient-focused medicine. Patient-centric approaches. These words have become so overused in the pharmaceutical industry that it’s hard to remember what they really mean: leading with empathy when it comes to serving patients. . Most patients engage with your pharmaceutical company because something is wrong.

Patients 52

Patients Pharma Medical Medicine 52

World of DTC Marketing

MARCH 25, 2021

SUMMARY: Johnson & Johnson and AstraZeneca publicly committed to not profiting off their products during the pandemic; Pfizer and Moderna made no such pledge and are already planning ways to make more money from their Covid vaccines. According to Moderna CEO Stéphane Bancel , we’ll likely need to get a COVID vaccine booster annually —and it may be part of a yearly medical ritual, he recently told Forbes.

Government 188

Government Sales Pharma Medical 188

World of DTC Marketing

MARCH 23, 2021

SUMMARY: Democratic lawmakers are weighing whether to include drug pricing measures that could extract tens of billions of dollars from the industry. “Something is coming. We’re just not sure when,” said one drug industry lobbying source. The industry should have seen this coming a long time ago as the excuse that they need high prices to fund R&D isn’t true anymore.

Distribution 187

Distribution Prescription FDA Pharma 187